Equity - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock from the exercise of options and warrants (in shares)	1,298,799
Authorized share repurchase program	$ 1,000,000,000
Shares repurchased (in shares)	2,070,054
Shares repurchased	$ 77,400,000
Remaining authorized share repurchase program	879,300,000
Reclassifications from AOCI to income	2,890,000	$ 2,937,000
Unrealized losses on hedging activities
Subsidiary, Sale of Stock [Line Items]
Reclassifications from AOCI to income	2,890,000	2,937,000
Interest rate swap | Unrealized losses on hedging activities
Subsidiary, Sale of Stock [Line Items]
Reclassifications from AOCI to income	2,900,000	2,900,000
Reclassifications to consolidated statement of operations, tax expense	$ 700,000	$ 700,000